Skip to content
1932

Health & Disease

Quiet couples: Alone time together

The right kind of silence can be golden, revitalizing and strengthening a relationship

Bringing the hospital into the home

A movement to provide hospital-level care for sick patients in their own beds, in the comfort of familiar surroundings, is growing in the United States — a trend already embraced in some other countries

We are all genetic mosaics

Picture your body: It’s a collection of cells carrying thousands of DNA errors accrued over a lifetime — many harmless, some bad, and at least a few that may be good for you.

Top science stories of 2024

This record-setting year for heat saw stunning auroras, a map of a brain, a Dengue epidemic, the first look at rocks from the far side of the Moon, an AI energy scramble and more

A devastating nerve disease stalks a mountain village

Neurologists have grappled with a cluster of amyotrophic lateral sclerosis cases in France, where a fondness for a toxic wild mushroom may hold the answer

The ones who need little sleep

Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects. Turns out they’re genetically built to require less sleep than the rest of us.

The great green building makeover

Getting our homes and workplaces to be energy efficient has major benefits — but not when it is done one window at a time. Here’s why deep retrofits and biomaterials are key to more sustainable living.

Frogs kick back against lethal fungus

Scientists are seeing signs of resistance to the infections that have been wiping out the world’s amphibian populations — and developing strategies to aid in the fight Down Under

Severe irritability in children and teens: A new understanding

Kids with disruptive mood dysregulation disorder have explosive outbursts well past toddler age. Scientists are trying to work out the causes and what treatments help.

When ribosomes go rogue

Unusual variations in the cellular protein factory can skew development, help cancer spread and more. But ribosome variety may also play biological roles, scientists say.

The Cybathlon: Bionic athletes compete for the gold — and push assistive technologies forward

In the international competition, people with physical disabilities put state-of-the-art devices to the test as they race to complete the tasks of everyday life

Studies of migraine’s many triggers offer paths to new therapies

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets.

Why a diabetes drug fell short of anticancer hopes

Population and animal studies suggested it could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

Your cells are dying. All the time.

Some go gently into the night. Others die less prettily in freak accidents or deadly invasions, or after a showy display.

Targeting the racial disparity in kidney disease

Some people of West African descent face a higher risk of renal failure. New drugs based on gene research may help right the ship — if they can reach everyone who needs them.

What if a virus could reverse antibiotic resistance?

In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d evolved to withstand

VIEW ALL

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error